Document is current
Any future updates will be listed below
-
Authors
Medina, Alejandro https://orcid.org/0000-0001-5609-2969
Jiménez, Cristina
Sarasquete, M. Eugenia
González, Marcos
Chillón, M. Carmen
Balanzategui, Ana
Prieto-Conde, Isabel https://orcid.org/0000-0002-2510-8355
García-Álvarez, María
Puig, Noemí
González-Calle, Verónica
Alcoceba, Miguel https://orcid.org/0000-0002-3819-4846
Cuenca, Isabel
Barrio, Santiago
Escalante, Fernando
Gutiérrez, Norma C.
Gironella, Mercedes
Hernández, Miguel T.
Sureda, Anna
Oriol, Albert
Bladé, Joan
Lahuerta, Juan-José
San Miguel, Jesús F.
Mateos, María-Victoria https://orcid.org/0000-0003-2390-1218
Martínez-López, Joaquín
Calasanz, María-José https://orcid.org/0000-0002-0374-3008
García-Sanz, Ramón https://orcid.org/0000-0003-4120-2787
-
Funding
Funding for this research was provided by:
EC | Directorate-General for Employment, Social Affairs and Inclusion | European Social Fund
Fundación Española de Hematología y Hemoterapia
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CPII18/00028, PI15/01956)
- License Information
-
More Information
Article History
Received: 4 September 2019
Revised: 16 January 2020
Accepted: 21 January 2020
First Online: 6 February 2020
Conflict of interest
: Authors report grants PI15/01956, CIBERONC-CB16/12/00233, and CEI-2010-1-0010 during the conduct of the study. A.M., M.G.-A., I.P.-C., C.J., V.G.-C. and M.E.S. are or were supported by the Spanish government. Authors have received honoraria from, consulted or served in an advisory role for, or are on the board of directors of Janssen (N.P., F.E., A.O., J.B., J.-J.L., J.F.S.M., M.-V.M., J.M.-L., R.G.-S.), Takeda (N.P., A.O., J.F.S.M., M.-V.M., R.G.-S.), Celgene (N.P., A.O., J.-J.L., J.F.S.M., M.-V.M.), Amgen (N.P., J.-J.L., J.F.S.M., M.-V.M), Bristol-Myers Squibb (J.F.S.M., M.-V.M., J.M.-L., R.G.-S.), Novartis (J.F.S.M., J.M.-L.), MSD (J.F.S.M.), Sanofi (J.F.S.M.), Roche (J.F.S.M.), Hospira (R.G.-S.), Pharmacyclics (R.G.-S.), Gilead (R.G.-S.) and Incyte (R.G.-S.). The remaining authors have no relevant conflict of interest to disclose.
